ISG15 is involved in chondrogenic differentiation through activation of IFN-γ signaling.

Biochem Biophys Res Commun

Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Kyunggi, 14068, South Korea; Institute for Skeletal Aging, Hallym University, Chunchon, 24251, South Korea. Electronic address:

Published: November 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Interferon-gamma (IFN-γ) was found to increase in the synovial fluid of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). However, few studies have been conducted to elucidate the role of IFN-γ in cartilage metabolism and regeneration. In this study, we investigated whether cartilage regeneration is driven by interferon-stimulated gene 15 (ISG15) under the control of IFN-γ. IFN-γ significantly increased ITS-induced chondrogenic differentiation of ATDC5 cells. Knockdown of IFN-γ receptor (IFN-γR) inhibited IFN-γ-induced chondrogenic differentiation and reduced ACAN and Col II expression. In addition, ISG15 expression was highly elevated in response to IFN-γ, whereas its expression was downregulated by knockdown of IFN-γR, indicating that ISG15 is closely related to IFN-γ signaling. Furthermore, chondrogenic differentiation and expression of ACAN and Col II were significantly reduced following knockdown of ISG15 in ATDC5 cells despite the presence of IFN-γ. ISGylation of cellular proteins found in chondrogenic differentiated cells was related to activation of IFN-γ signaling. In addition, ISG15/ISGylation was significantly observed in the regenerated cartilage tissue 7 days after FTCI of young mice compared with sham control. Our findings showed that upregulation of ISG15 and/or ISGylation of cellular proteins may play a critical role in cartilage regeneration through activation of IFN-γ signaling.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2024.150629DOI Listing

Publication Analysis

Top Keywords

chondrogenic differentiation
16
ifn-γ signaling
16
activation ifn-γ
12
ifn-γ
11
cartilage regeneration
8
atdc5 cells
8
acan col
8
isgylation cellular
8
cellular proteins
8
isg15
6

Similar Publications

CXXC Finger Protein 1 drives BMP signaling and progenitor cell differentiation during limb development.

Dev Biol

September 2025

Division of Endocrinology, Boston Children's Hospital, Boston, MA 02115 USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115 USA; Harvard Stem Cell Institute, 7 Divinity Ave, Cambridge, MA 02138 USA. Electronic address:

The mechanisms mediating endochondral bone formation remain incompletely understood. Here, we show that CXXC Finger Protein 1 (CFP1) is required for the onset of chondrogenesis during forelimb development. CFP1-deficient mesenchymal progenitor cells (LMPs) retain an immature molecular signature with elevated FGF and SHH signaling and repressed BMP signaling, in part, due to (1) reduced expression of type I BMP receptors, (2) reduced Smad1 protein levels and (3) an altered extracellular niche.

View Article and Find Full Text PDF

MHC compatibility influences the interaction between different types of equine mesenchymal stem/stromal cells and the local immune response.

Res Vet Sci

September 2025

Laboratorio de Genética Bioquímica LAGENBIO - Instituto de Investigación Sanitaria de Aragón (IIS) - Instituto Agroalimentario de Aragón-IA2, Universidad de Zaragoza-CITA, Zaragoza, Spain; Servicio de Cirugía y Medicina Equina, Hospital Veterinario, Universidad de Zaragoza, Zaragoza, Spain. El

The allogeneic administration of equine mesenchymal stem/stromal cells (MSCs) has numerous advantages over autologous therapy, but their interactions with the patient's immune system need to be further elucidated. These interactions can be influenced by factors such as the compatibility between donor-receptor for the major histocompatibility complex (MHC) and by the MHC expression levels, which can change under different conditions like inflammatory exposure and chondrogeneic differentiation. In this study, we evaluated the local immune response induced by chondrogeneically differentiated (MSC-chondro), pro-inflammatory primed (MSC-primed) and basal (MSC-naïve) MSCs, and how this response changes the immunomodulatory and immunogenic profiles of MSCs in vivo.

View Article and Find Full Text PDF

Kartogenin-encapsulated self-healing injectable hydrogel based on hyaluronic acid and chitosan derivative for use as viscosupplementation in knee osteoarthritis.

Int J Biol Macromol

September 2025

Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand; Bioplastics Production Laboratory for Medical Applications, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Materials Science and Technology, Chiang Mai Univ

Early osteoarthritis treatment often relies on viscosupplementation via intra-articular injections, which are limited by inflammation risk and poor cartilage restoration. To address these issues, self-healing hydrogels provide a promising alternative because of their ability to recover structure after mechanical stress. This study reports an injectable self-healing hydrogel composed of N-succinyl chitosan (NSC) and hyaluronic dialdehyde (HAD), combined with kartogenin (KGN), synthesized under mild conditions via Schiff base reactions.

View Article and Find Full Text PDF

This study aimed to evaluate the effects of cell-derived (BMSCs and chondrocytes) extracellular matrix (ECM) scaffolds incorporating bone marrow aspirate concentrate (BMAC) on cartilage regeneration, and to determine whether BMAC-loaded BMSCs-derived (BM-d) ECM scaffolds were comparable to chondrocytes-derived (Ch-d) ECM scaffolds in terms of cartilage regeneration. In this study, BMSCs and chondrocytes were harvested and isolated, then developed into BM-d and Ch-d ECM scaffolds. The scaffolds were fully immersed in BMAC and subsequently utilized for inducing chondrogenic differentiation in vitro and cartilage regeneration in vivo.

View Article and Find Full Text PDF

Traumatic heterotopic ossification (THO) is a pathological process characterized by ectopic bone formation in soft tissues following trauma or surgical interventions, leading to pain, swelling, and restricted mobility. Current therapeutic strategies remain limited, with surgical excision often associated with recurrence and complications. Triptolide (TP), a diterpenoid triepoxide derived from Tripterygium wilfordii, has potent anti-inflammatory and immunomodulatory effects, making it a promising candidate for THO treatment.

View Article and Find Full Text PDF